Eversept Partners, LP Tandem Diabetes Care Inc Transaction History

Eversept Partners, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Nov 08, 2023	BUY	$53.22 - $123.09 $13.6 Million - $31.5 Million	256,268 New	256,268 $15.2 Million
Q2 2022 Aug 15, 2022	BUY	$53.22 - $123.09 $13.6 Million - $31.5 Million	256,268 New	256,268 $15.2 Million
Q3 2018 Nov 14, 2018	SELL	$21.39 - $51.17 $1.31 Million - $3.14 Million	-61,300 Closed	0 $0
Q2 2018 Nov 08, 2023	BUY	$4.9 - $23.64 $300,370 - $1.45 Million	61,300 New	61,300 $1.35 Million
Q2 2018 Aug 14, 2018	BUY	$4.9 - $23.64 $300,370 - $1.45 Million	61,300 New	61,300 $1.35 Million

354

71.9M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.28B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.